PSILOCYBIN
Clinical trials for PSILOCYBIN explained in plain language.
Never miss a new study
Get alerted when new PSILOCYBIN trials appear
Sign up with your email to follow new studies for PSILOCYBIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Magic mushroom compound may shield cancer patients from nerve pain
Prevention Not yet recruitingThis study tests whether psilocybin, a natural compound, can prevent or lessen nerve damage caused by chemotherapy in people with breast, colorectal, or head and neck cancer. About 83 participants will receive psilocybin, a placebo, or standard care before starting chemo. The goa…
Matched conditions: PSILOCYBIN
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated May 26, 2026 08:33 UTC
-
Magic mushroom compound tested as pain therapy booster
Symptom relief Not yet recruitingThis study tests whether a single dose of psilocybin can improve how people with chronic low back pain sense their body, and whether that leads to less pain and better results from physical therapy. About 45 adults aged 18-65 with long-lasting low back pain will take psilocybin a…
Matched conditions: PSILOCYBIN
Phase: PHASE2 • Sponsor: Yale University • Aim: Symptom relief
Last updated May 26, 2026 08:34 UTC
-
Magic mushroom therapy for depression? new study tests group approach
Symptom relief Not yet recruitingThis study will test whether psilocybin (the active ingredient in magic mushrooms) combined with cognitive behavioral therapy in a group setting is acceptable and feasible for people with major depression. Thirty adults aged 21-60 with current depressive symptoms will participate…
Matched conditions: PSILOCYBIN
Phase: PHASE2 • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated May 20, 2026 11:55 UTC
-
Magic mushroom compound studied in healthy volunteers
Knowledge-focused Not yet recruitingThis study gives 50 healthy adults a single dose of psilocybin (the active ingredient in magic mushrooms) or a placebo to measure changes in brain waves, blood chemicals, and empathy. Participants must have never used psychedelics before. The goal is to understand how psilocybin …
Matched conditions: PSILOCYBIN
Phase: PHASE1 • Sponsor: Gabriella Gobbi • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC